Introduction: Who Should Undergo Diagnostics

Anyone diagnosed with systemic lupus erythematosus (SLE)—the most common form of lupus—should undergo regular kidney screening, even if they feel completely well. Lupus is a disease where the body’s defense system turns against its own tissues and organs, and the kidneys are among its most frequent targets. About half of adults with lupus will develop lupus nephritis, and the percentage is even higher in children, affecting roughly 80% of young patients with lupus.^[3][2]

The tricky part about lupus nephritis is that it often develops gradually and can be present even when you don’t notice anything wrong. Most commonly, kidney involvement appears within three to five years after lupus symptoms first show up, though it can sometimes be the very first sign that someone has lupus at all.^[4] This silent progression makes regular monitoring absolutely crucial.

You should seek diagnostic testing right away if you notice specific warning signs. These include blood in your urine, urine that appears foamy due to excess protein, swelling in your legs or around your eyes, unexplained weight gain from fluid buildup, increased urination especially at night, or high blood pressure that’s difficult to control.^[1][2] However, waiting for symptoms to appear is not the best approach. Because kidney damage can occur silently, routine screening every six to twelve months is strongly recommended for all lupus patients who don’t yet have known kidney disease.^[13]

Certain groups of people face higher risks and should be especially vigilant about screening. Women are much more likely to develop lupus than men—nine out of ten lupus patients are women—though interestingly, men who do develop lupus are more likely to experience kidney involvement.^[3] People of Black, Native American, Hispanic or Latino, Pacific Islander, and Asian descent face both higher rates of lupus nephritis and more severe disease.^[3] The condition is particularly common in women between ages 15 and 44, which happens to be the prime child-bearing years, making early detection even more important for family planning purposes.^[9]

If you’re experiencing a flare-up of other lupus symptoms—such as joint pain, skin rashes, fever, or fatigue—your doctor should also check your kidney function during this time. Kidney involvement often becomes active when lupus is affecting other parts of the body as well.^[7]

Diagnostic Methods for Identifying Lupus Nephritis

When doctors suspect lupus nephritis, they use a combination of tests to confirm the diagnosis and understand how severely the kidneys are affected. The process typically starts with simple screening tests and may progress to more detailed examinations if problems are found.

Blood Tests

Blood tests provide essential information about how well your kidneys are filtering waste from your bloodstream. The most commonly used blood tests include measurements of blood urea nitrogen (BUN) and serum creatinine—both are waste products that healthy kidneys should remove efficiently.^[7] When kidney function declines, these waste products accumulate in the blood, causing the test values to rise above normal ranges.

Beyond basic kidney function, doctors also look at specific markers that indicate lupus disease activity. Testing for antibodies to double-stranded DNA (anti-dsDNA) helps confirm active lupus, as these proteins are particularly associated with lupus nephritis.^[7] Low levels of complement proteins (C3, C4, and CH50) in the blood suggest that your immune system is actively attacking tissues, including potentially the kidneys. These complement proteins are part of the body’s defense system, and they get “used up” during the inflammatory process that damages the kidneys.^[7]

Urine Tests

Urine testing is one of the most important and straightforward ways to detect kidney problems in lupus patients. A basic urinalysis examines a urine sample for abnormal contents. Healthy kidneys prevent protein and red blood cells from leaking into urine, so finding these substances is a red flag for kidney damage.^[7]

When protein appears in urine—a condition called proteinuria—it often makes the urine look foamy or frothy, like dishwater after washing dishes. Doctors typically measure the amount of protein using either a spot urine test that compares protein to creatinine concentration, or by collecting all urine produced over a 24-hour period to calculate total protein loss.^[7] If you have high levels of protein in your urine (more than 0.5 grams per gram of creatinine), this is a strong indication that lupus may be affecting your kidneys.^[13]

Finding red blood cells or cellular casts in urine under the microscope also signals kidney inflammation. These casts are tiny tube-shaped structures formed in the kidney’s filtering units, and their presence indicates active damage to the kidney tissue.^[6]

Kidney Biopsy

A kidney biopsy is considered the gold standard for diagnosing and classifying lupus nephritis. While it sounds intimidating, this procedure provides crucial information that blood and urine tests cannot reveal. During a biopsy, a doctor uses a needle to remove a small piece of kidney tissue—just a tiny sample of cells—which is then examined under a microscope by a specialist.^[3]

Healthcare providers generally recommend a kidney biopsy when urine tests show significant protein levels (greater than 0.5 grams per gram) and when kidney function tests are abnormal without another clear explanation.^[13] The biopsy results tell doctors exactly what type and class of lupus nephritis you have, which directly guides treatment decisions. There are six classes of lupus nephritis, ranging from minimal changes (Class I) to advanced scarring (Class VI), and each class requires different treatment approaches.^[6]

The biopsy also reveals whether the kidney damage is active inflammation that can potentially be reversed with treatment, or if permanent scarring has already occurred. This distinction is extremely important because aggressive treatment is most beneficial when inflammation is active and damage is still reversible.^[4]

Understanding the specific pattern of kidney damage helps doctors predict how the disease might progress and which medications will work best. For instance, Class III and Class IV lupus nephritis (focal and diffuse proliferative types) are more aggressive forms that typically require stronger immunosuppressive medications, while Class V (membranous) may be treated somewhat differently.^[7]

Imaging Tests

While not always necessary for diagnosis, imaging studies can provide additional information about your kidneys. An ultrasound of the kidneys is a painless test that uses sound waves to create pictures of the kidney structure. It can show the size and shape of the kidneys and identify any unusual features or complications, though it cannot show the microscopic damage that causes lupus nephritis.^[3]

Physical Examination

Your doctor will also conduct a physical examination looking for signs of kidney problems and active lupus disease. They’ll check your blood pressure, since high blood pressure often accompanies kidney disease. They’ll look for swelling (edema) in your legs, ankles, feet, or around your eyes, which happens when damaged kidneys cannot properly regulate fluid and protein balance in your body.^[3] The doctor will also examine your skin for rashes, check your joints for inflammation, and look for other signs that lupus may be affecting multiple organ systems beyond just the kidneys.^[7]

Diagnostics for Clinical Trial Qualification

When patients consider participating in clinical trials testing new treatments for lupus nephritis, they undergo specific diagnostic evaluations to determine if they meet the study requirements. Clinical trials have strict criteria about which patients can participate, and these criteria are designed to ensure patient safety and help researchers get accurate results about whether a treatment works.

Standard Screening Tests

Clinical trial screening typically begins with the same basic tests used in regular clinical practice: blood tests measuring kidney function (BUN and creatinine), urine tests checking for protein and blood cells, and blood tests looking at lupus disease activity markers like anti-dsDNA antibodies and complement levels.^[7] However, trials often require that these abnormalities fall within specific ranges. For example, a trial might only accept patients with a certain minimum level of protein in their urine, or those whose blood tests show their kidneys are functioning within a particular range.

Kidney Biopsy Requirements

Many clinical trials require a recent kidney biopsy—often within the past several months—that confirms a specific class or type of lupus nephritis. This ensures that all patients in the study have similar disease patterns, which makes it easier to tell if the experimental treatment is helping.^[4] The biopsy might need to show active inflammation rather than just scarring, since new treatments typically aim to stop ongoing damage rather than reverse permanent changes.

Researchers examining biopsy samples under the microscope look for specific features. They assess the degree of inflammation in different parts of the kidney’s filtering units (the glomeruli), check for immune complex deposits, and determine how much scarring has occurred. An electron microscope may be used to see extremely detailed structures, and special staining techniques help identify the types of immune proteins attacking the kidney tissue.^[6]

Disease Activity Measurements

Clinical trials often use standardized measures of disease activity to select participants and track whether treatments are working. These might include calculating the urine protein-to-creatinine ratio from a single urine sample, or measuring the total amount of protein lost in urine over 24 hours. A common trial requirement is a protein-to-creatinine ratio above a certain threshold, which indicates active kidney damage that needs treatment.^[4]

Researchers also track changes in kidney filtering ability using blood creatinine measurements to estimate something called the glomerular filtration rate (GFR). This calculation estimates how much blood your kidneys can filter per minute. Clinical trials typically require that participants have a GFR within a certain range—not so low that the kidneys are too damaged to potentially benefit from treatment, but not so high that there isn’t room to show improvement.^[4]

Additional Laboratory Assessments

Beyond standard kidney and lupus tests, clinical trials often perform additional laboratory work to ensure participants are healthy enough for experimental treatments and don’t have conditions that might interfere with the study. This can include complete blood counts to check for anemia or problems with white blood cells or platelets, liver function tests, tests for infections like tuberculosis or hepatitis, and pregnancy tests for women of childbearing age.^[7]

Some trials test for specific genetic markers or measure certain proteins in the blood that might predict who will respond best to a new treatment. These specialized tests help researchers understand not just whether a treatment works, but also which patients are most likely to benefit from it in the future.

Monitoring Throughout the Trial

Once enrolled in a clinical trial, participants undergo frequent repeated testing to monitor both safety and effectiveness. This typically includes regular blood and urine tests at scheduled intervals—often monthly or every few months—to watch for improvement in kidney function and to catch any side effects of the experimental treatment early. The frequency and types of monitoring in clinical trials are usually much more intensive than in routine clinical care, providing extremely detailed information about how the disease and treatment are affecting the kidneys over time.^[4]

The goal of these comprehensive diagnostic evaluations is to match the right patients with the right clinical trials, maximize safety, and generate high-quality data that will help determine if new treatments should be approved for widespread use in the future. While the testing requirements can feel overwhelming, they serve important purposes in advancing lupus nephritis treatment options for everyone.